Genotypic tropism testing in proviral DNA to guide maraviroc initiation in aviremic subjects: 48-week analysis of the PROTEST study

INTRODUCTION: In a previous interim 24-week virological safety analysis of the PROTEST study [1], initiation of Maraviroc (MVC) plus 2 nucleoside reverse-transcriptase inhibitors (NRTIs) in aviremic subjects based on genotypic tropism testing of proviral HIV-1 DNA was associated with low rates of vi...

詳細記述

保存先:
書誌詳細
出版年:J Int AIDS Soc
主要な著者: Garcia, Federico, Poveda, Eva, Jesús Pérez-Elías, Maria, Hernández Quero, José, Àngels Ribas, Maria, Martínez-Madrid, Onofre J, Flores, Juan, Crespo, Manel, Gutiérrez, Félix, García-Deltoro, Miguel, Imaz, Arkaitz, Ocampo, Antonio, Artero, Arturo, Blanco, Francisco, Bernal, Enrique, Pasquau, Juan, Mínguez-Gallego, Carlos, Pérez, Núria, Aiestarán, Aintzane, Paredes, Roger
フォーマット: Artigo
言語:Inglês
出版事項: International AIDS Society 2014
主題:
Oral Presentation – Abstract O334
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4224842/
https://ncbi.nlm.nih.gov/pubmed/25394029
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7448/IAS.17.4.19520
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料